Skip to content

Clinical trials

Cardiovascular Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Russia Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20031
20052
20062
20082
20097
20101
20114
20126
20133
20143
20162
20172
20185
20191
20208
20215
20224
20234
20241
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed44
Unknown status9
Terminated8
Recruiting7
Active, not recruiting3
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
I.M. Sechenov First Moscow State Medical University7
National Medical Research Center for Therapy and Preventive Medicine5
GlaxoSmithKline4
Takeda4
AstraZeneca2
Bayer2
Eli Lilly and Company2
Eurasian Association of Therapists2
Meshalkin Research Institute of Pathology of Circulation2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases74
Coronary Artery Disease10
Heart Diseases10
Atherosclerosis9
Heart Failure9
Myocardial Infarction9
Stroke9
Vascular Diseases9
Coronary Disease7
Acute Coronary Syndrome6

Trials

Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.